Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Not ...
Global obesity-drug sales could exceed $130–150B by the mid-2030s, driven by GLP-1/GIP drugs and expanding access beyond the U.S. Lilly strengthens its leadership with a deep pipeline, while Novo ...
From L-R: Betty Pio, partner at Kearney; Dr. Rekha Kumar, chief medical officer at Found and practicing endocrinologist at New York-Presbyterian; Sheila Shah, managing director, L.E.K. Consulting; ...
The sudden popularity of drugs like Ozempic and Wegovy for weight loss created a multibillion-dollar market overnight. Healthcare companies want a piece of it. The weight-loss space is quickly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results